Receipt-based marketing software that helps brands connect advertising campaigns with customers' actual purchases.
Global Brain
Activity from announced rounds
Global Brain is a Japanese investment corporation, also recorded under the expanded name Global Brain Corporation.
Recorded funding activity
The firm’s own announcements connect it to WED’s receipt-based marketing and RegCell’s cell therapies for autoimmune disease. Other covered activity includes 10pct.’s combination of hotel operations and AI software. Named corporate and flagship funds remain separate.
- Rounds participated in
- 7
- Confirmed lead rounds
- 1 2 roles undisclosed
- New companies
- 7 First participation on record · 0 follow-on
- Funding in participating rounds
- $144.3M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
2 more
By country
Rounds
7 in this selectionRegCell is developing cell therapies for autoimmune disease by epigenetically reprogramming pathogenic conventional T cells into stable regulatory T cells, aiming to restore immune tolerance without gene engineering; its platform is advancing toward clinical development.
A hotel operator combining property-management experience with AI software and regional tourism services.
Reframe Systems is a design-build homebuilder using local automated microfactories to deliver high-performance homes.
Develops a quantum- and AI-enabled optimization platform for enterprises
Startup dedicated to realizing fusion energy
AlixLabs develops atomic-layer etching processes and equipment for semiconductor manufacturers making smaller, more densely packed chip features.